Led · Series A · Mar 2026

Nectir builds secure AI infrastructure purpose-built for schools, colleges, and universities that enables institutions to deploy custom AI assistants integrated with institutional knowledge and learning management systems. The platform offers 24/7 personalized learning support grounded in course content and supports students, faculty, and administrators. Nectir is used by more than 80,000 students across over 100 campuses, including Stanford University and multiple community colleges. The company was founded by Kavitta Ghai and Jordan Long and is based in San Francisco. Following its March 2026 $12.5 million Series A led by Rethink Impact with participation from Gingerbread Capital and Strada, Nectir plans to use the funding to scale its AI infrastructure and expand deployments across educational institutions. The business focuses on secure, institution-specific deployments that integrate with existing LMS platforms.

Participated · Series A · Dec 2025

Clarity Pediatrics operates a tech-enabled virtual clinic that delivers American Academy of Pediatrics–aligned specialty care for chronic pediatric conditions such as ADHD and anxiety. More than 1,600 pediatricians in California and Texas already refer both commercial and Medicaid patients to the service, which integrates medical oversight, behavioral therapy, and parent coaching, all covered by insurance. Outcomes to date are encouraging: 89% of participating parents report a ‘large’ impact on their lives and 75% see improvement in child behaviors after eight weeks. The company plans to launch obesity care in early 2026, broadening its multi-specialty offering to address one of the fastest-growing pediatric health issues. Funding will also support continued development of its virtual platform and geographic expansion across the United States. Clarity’s model emphasizes family-centered group care delivered by pediatricians and specialists working at the top of their licenses. The company is headquartered in San Francisco and is backed by several prominent venture investors.

Participated · Series B · Dec 2025

Founded in 2021, Parallel Learning delivers psychoeducational assessments, speech-language pathology, behavioral and mental-health counseling, and specialized instruction entirely online via its Pathway platform. The system combines secure teletherapy, licensed clinicians, AI-driven personalization, and data-rich progress tracking to support understaffed school districts. During the 2024–2025 academic year, 98 % of the more than 10,000 students it serves met or exceeded their IEP goals, with particularly strong outcomes in behavioral health (94.3 % exceeding expectations). The company currently operates in 25 states, and many of its users come from communities with high Social Vulnerability Index scores. Student satisfaction is high, with Routine Outcome Monitoring scores averaging 8.9/10 for provider experience and 8.6/10 for overall well-being. Parallel plans to use new capital to scale nationwide, deepen AI integration, and broaden access across all 50 states. The firm has previously attracted investors such as Tiger Global, Vine Ventures, Obvious Ventures, and Rethink Impact.

Led · Series A · Oct 2025

Founded in 2020 by Harvard Business School classmates Tina Keshani, Julia Cole, and Sophia Richter, Seven Starling delivers technology-enabled maternal mental-health care. Its platform combines clinical evaluations, medication management, and both individual and group therapy to treat depression, anxiety, and related conditions tied to parenthood. All services are covered by insurance, helping patients access support without prohibitive out-of-pocket costs. The company plans to use new capital to expand into a dozen additional states by the end of 2026. Seven Starling’s care model targets postpartum, infertility, miscarriage, and loss, aiming to close gaps in traditional maternal health services. To date, the startup has raised $21.8 million across three rounds, giving it resources to scale its virtual operations and provider network.

Participated · Series A · Sep 2025

Andromeda builds Abi, a next-generation humanoid companion robot and has launched its latest model. The company will begin first deployments at a mecwacare aged care home this month. Andromeda plans to focus initially on aged care as it expands into the US while continuing to scale operations and teams in Australia. The raise is intended to accelerate US expansion, fast-track the Australian waitlist, and support hiring across engineering and customer success. In the US the company is prioritising recruitment of creative and animation robotics specialists. Andromeda emphasised the funding will help bring Abi’s companionship to more customers and partners across aged care and other sectors. Andromeda Robotics builds Abi, a humanoid companion robot designed to provide companionship and support to older adults in aged care facilities and children in hospitals. Abi was developed with input from Disney and Pixar animators and uses AI and machine learning to customize interactions, respond to questions, express emotions, recognize faces, and remember past interactions. The robot assists with daily tasks and offers social and cognitive support to enhance users' quality of life and independence. Abi's personality will be customizable through an upcoming app, with options such as a 'sarcastic coach' highlighted as popular. Andromeda has progressed with limited funding and recently raised a $3 million seed round to scale Abi across Australia. The company plans to use the new capital to improve Abi's capabilities, grow the team, and move to larger manufacturing facilities in South Melbourne.